Kidswell Bio Corporation (TYO:4584)
Japan
· Delayed Price · Currency is JPY 251.00
-28.00 (-10.04%)
Jul 1, 2025, 3:30 PM JST
Kidswell Bio Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2015 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2015 - 2018 |
Net Income | 72 | -533 | -999 | -7,314 | -856.29 | Upgrade
|
Depreciation & Amortization | - | 2 | - | - | 0.32 | Upgrade
|
Loss (Gain) From Sale of Assets | 6 | - | 1 | 5,982 | - | Upgrade
|
Asset Writedown & Restructuring Costs | - | - | - | - | 0.4 | Upgrade
|
Loss (Gain) From Sale of Investments | -35 | -417 | 7 | -4 | - | Upgrade
|
Other Operating Activities | -5 | -1 | -2 | -3 | 2.25 | Upgrade
|
Change in Accounts Receivable | -385 | 354 | -174 | -89 | -154.31 | Upgrade
|
Change in Inventory | -599 | -538 | -196 | -101 | -11.93 | Upgrade
|
Change in Accounts Payable | 56 | -171 | 265 | -207 | -3.39 | Upgrade
|
Change in Other Net Operating Assets | 1,826 | 135 | -169 | 411 | 162.65 | Upgrade
|
Operating Cash Flow | 936 | -1,169 | -1,267 | -1,325 | -860.32 | Upgrade
|
Capital Expenditures | -6 | - | - | -1 | - | Upgrade
|
Cash Acquisitions | - | - | - | 12 | - | Upgrade
|
Divestitures | - | - | -14 | - | - | Upgrade
|
Sale (Purchase) of Intangibles | - | - | -3 | - | - | Upgrade
|
Investment in Securities | 74 | 526 | - | -94 | - | Upgrade
|
Other Investing Activities | -3 | - | -5 | -4 | -0.03 | Upgrade
|
Investing Cash Flow | 65 | 526 | -22 | -137 | -0.03 | Upgrade
|
Long-Term Debt Issued | - | - | 599 | 1,181 | - | Upgrade
|
Total Debt Issued | - | - | 599 | 1,181 | - | Upgrade
|
Short-Term Debt Repaid | - | - | -25 | - | - | Upgrade
|
Long-Term Debt Repaid | -748 | - | - | - | - | Upgrade
|
Total Debt Repaid | -748 | - | -25 | - | - | Upgrade
|
Net Debt Issued (Repaid) | -748 | - | 574 | 1,181 | - | Upgrade
|
Issuance of Common Stock | 508 | 369 | 143 | 43 | 973.09 | Upgrade
|
Other Financing Activities | - | - | 1 | -3 | 5.35 | Upgrade
|
Financing Cash Flow | -240 | 369 | 718 | 1,221 | 978.45 | Upgrade
|
Foreign Exchange Rate Adjustments | 2 | - | - | - | - | Upgrade
|
Miscellaneous Cash Flow Adjustments | 1 | 1 | - | 264 | -0 | Upgrade
|
Net Cash Flow | 764 | -273 | -571 | 23 | 118.1 | Upgrade
|
Free Cash Flow | 930 | -1,169 | -1,267 | -1,326 | -860.32 | Upgrade
|
Free Cash Flow Margin | 18.30% | -74.51% | -127.21% | -123.12% | -84.20% | Upgrade
|
Free Cash Flow Per Share | 22.96 | -37.89 | -44.01 | -47.97 | -44.05 | Upgrade
|
Cash Interest Paid | 46 | 15 | 15 | 5 | - | Upgrade
|
Cash Income Tax Paid | 1 | 1 | 2 | 2 | 1.9 | Upgrade
|
Levered Free Cash Flow | - | -895.75 | -954.63 | -753.19 | -519 | Upgrade
|
Unlevered Free Cash Flow | - | -886.38 | -945.25 | -750.06 | -519 | Upgrade
|
Change in Net Working Capital | - | 314 | 336 | 22.81 | 16.09 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.